Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Legge

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|December 8, 1998
Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergyB Min, K L Legge, C Pack, et al.
The Journal of Experimental Medicine|March 17, 1997
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processingK L Legge, B Min, N T Potter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Differential presentation of an altered peptide within fetal central and peripheral organs supports an avidity model for thymic T cell development and implies a peripheral readjustment for activationK L Legge, B Min, C Pack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
TCR agonist and antagonist exert in vivo cross-regulation when presented on IgsK L Legge, B Min, A E Cestra, et al.
Cellular Immunology|March 16, 2000
Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvantB Min, K L Legge, J C Caprio, et al.
International Reviews of Immunology|March 14, 2002
Multi-modal antigen specific therapy for autoimmunityK L Legge, J J Bell, L Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responsesL Li, K L Legge, B Min, et al.
The Journal of Experimental Medicine|March 8, 2000
High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoireA C Anderson, L B Nicholson, K L Legge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergyB Min, K L Legge, J J Bell, et al.
The Journal of Experimental Medicine|June 22, 2000
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitisK L Legge, B Min, J J Bell, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|December 8, 1998
Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergyB Min, K L Legge, C Pack, et al.
The Journal of Experimental Medicine|March 17, 1997
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processingK L Legge, B Min, N T Potter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Differential presentation of an altered peptide within fetal central and peripheral organs supports an avidity model for thymic T cell development and implies a peripheral readjustment for activationK L Legge, B Min, C Pack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
TCR agonist and antagonist exert in vivo cross-regulation when presented on IgsK L Legge, B Min, A E Cestra, et al.
Cellular Immunology|March 16, 2000
Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvantB Min, K L Legge, J C Caprio, et al.
International Reviews of Immunology|March 14, 2002
Multi-modal antigen specific therapy for autoimmunityK L Legge, J J Bell, L Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responsesL Li, K L Legge, B Min, et al.
The Journal of Experimental Medicine|March 8, 2000
High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoireA C Anderson, L B Nicholson, K L Legge, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergyB Min, K L Legge, J J Bell, et al.
The Journal of Experimental Medicine|June 22, 2000
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitisK L Legge, B Min, J J Bell, et al.
Pageof 2